Presence of autoantibodies in serum does not impact the occurrence of immune checkpoint inhibitor-induced hepatitis in a prospective cohort of cancer patients

Purde, Mette-Triin; Niederer, Rebekka; Wagner, Nikolaus B.; Diem, Stefan; Berner, Fiamma; Hasan Ali, Omar; Hillmann, Dorothea; Bergamin, Irina; Joerger, Markus; Risch, Martin; Niederhauser, Christoph; Lenz, Tobias L.; Fruh, Martin; Risch, Lorenz; Semela, David; Flatz, Lukas

dc.contributor.author	Flatz, Lukas
dc.date.accessioned	2022-05-23T08:38:45Z
dc.date.available	2022-05-23T08:38:45Z
dc.date.issued	2022
dc.identifier.issn	0171-5216
dc.identifier.uri	http://hdl.handle.net/10900/127186
dc.language.iso	en	de_DE
dc.publisher	New York	de_DE
dc.relation.uri	http://dx.doi.org/10.1007/s00432-021-03870-6	de_DE
dc.subject.ddc	610	de_DE
dc.title	Presence of autoantibodies in serum does not impact the occurrence of immune checkpoint inhibitor-induced hepatitis in a prospective cohort of cancer patients	de_DE
dc.type	Article	de_DE
utue.quellen.id	20220404000000_00189
utue.publikation.seiten	647-656	de_DE
utue.personen.roh	Purde, Mette-Triin
utue.personen.roh	Niederer, Rebekka
utue.personen.roh	Wagner, Nikolaus B.
utue.personen.roh	Diem, Stefan
utue.personen.roh	Berner, Fiamma
utue.personen.roh	Hasan Ali, Omar
utue.personen.roh	Hillmann, Dorothea
utue.personen.roh	Bergamin, Irina
utue.personen.roh	Joerger, Markus
utue.personen.roh	Risch, Martin
utue.personen.roh	Niederhauser, Christoph
utue.personen.roh	Lenz, Tobias L.
utue.personen.roh	Fruh, Martin
utue.personen.roh	Risch, Lorenz
utue.personen.roh	Semela, David
utue.personen.roh	Flatz, Lukas
dcterms.isPartOf.ZSTitelID	Journal of Cancer Research and Clinical Oncology	de_DE
dcterms.isPartOf.ZS-Issue	3	de_DE
dcterms.isPartOf.ZS-Volume	148	de_DE
utue.fakultaet	04 Medizinische Fakultät	de_DE